THERESE BELL: Open Payments
NPI 1881239549 · WESTMONT, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,197 in 59 payments from 13 companies in 2025. Trend: 2023 $13 · 2024 $1,118 · 2025 $1,197
Food & beverage: $1,197
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $316 |
| ABBVIE INC. | 12 | $189 |
| Novo Nordisk Inc | 8 | $145 |
| GlaxoSmithKline, LLC. | 5 | $94 |
| Exact Sciences Corporation | 4 | $89 |
| Amgen Inc. | 4 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $61 |
| Kowa Pharmaceuticals America, Inc. | 3 | $44 |
| Lilly USA, LLC | 2 | $42 |
| Phathom Pharmaceuticals, Inc. | 2 | $42 |
Products named: AIRSUPRA, VRAYLAR, FARXIGA, JARDIANCE, SHINGRIX, Wegovy, Ozempic, UBRELVY.
Industry payments across IL — which companies pay providers there.
